BioMarin Announces Record Revenues in Second Quarter 2022; Increases Full-year 2022 Top and Bottom-line Guidance
Go back to BioMarin Announces Record Revenues in Second Quarter 2022; Increases Full-year 2022 Top and Bottom-line Guidance| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 59.29 -0.68 (1.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.97 | 52 Week High | $108.96 | |||
| Open | $60.15 | 52 Week Low | $62.12 | |||
| Day High | $60.28 | P/E | N/A | |||
| Day Low | $58.44 | EPS | $-1.27 | |||
| Volume | 336,370 | |||||

